Cardiac laminopathy in familial partial lipodystrophy type 2 secondary to variants in the LMNA gene

被引：0
|
作者：
Moreno Tirado, Antonio [1 ]
Rodriguez Ortega, Pilar [1 ]
Calle Isorna, Jose Maria [2 ]
机构：
[1] Hosp Univ Juan Ramon Jimenez, Huelva, Spain
[2] Hosp Univ Virgen Macarena, Huelva, Spain
来源：
MEDICINA CLINICA | 2024年 / 163卷 / 12期
关键词：
D O I：
10.1016/j.medcli.2024.06.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：634 / 635
页数：2
相关论文
共 50 条
  • [1] Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene
    Araujo-Vilar, David
    Sanchez-Iglesias, Sofia
    Castro, Ana I.
    Cobelo-Gomez, Silvia
    Hermida-Ameijeiras, Alvaro
    Rodriguez-Carnero, Gemma
    Casanueva, Felipe F.
    Fernandez-Pombo, Antia
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 9
  • [2] Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
    Vasandani, Chandna
    Li, Xilong
    Sekizkardes, Hilal
    Brown, Rebecca J.
    Garg, Abhimanyu
    JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 6 (12)
  • [3] Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases
    Morguetti, Maria Julia
    Neves, Precil Diego Miranda de Menezes
    Korkes, Ilana
    Padilha, Wallace Stwart Carvalho
    Jorge, Lecticia Barbosa
    Watanabe, Andreia
    Watanabe, Elieser Hitoshi
    Malheiros, Denise Maria Avancini Costa
    Noronha, Irene de Lourdes
    Dib, Sergio Atala
    Onuchic, Luiz Fernando
    Moises, Regina S.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68
  • [4] Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene
    D. B. Savage
    I. McFarlane
    I. Barroso
    M. A. Soos
    A. Powlson
    E. L. Thomas
    J. D. Bell
    I. Scobie
    P. E. Belchetz
    W. F. Kelly
    D. J. Halsall
    A. J. Schafer
    S. O’Rahilly
    Diabetologia, 2004, 47 : 753 - 756
  • [5] Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene
    Owen, KR
    Donohoe, M
    Ellard, S
    Hattersley, AT
    DIABETIC MEDICINE, 2003, 20 (10) : 823 - 827
  • [6] Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene
    Savage, DB
    Soos, MA
    Powlson, A
    O'Rahilly, S
    McFarlane, I
    Halsall, DJ
    Barroso, I
    Thomas, EL
    Bell, JD
    Scobie, I
    Belchetz, PE
    Kelly, WF
    Schafer, AJ
    DIABETOLOGIA, 2004, 47 (04) : 753 - 756
  • [7] Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review
    Fernandez-Pombo, Antia
    Diaz-Lopez, Everardo Josue
    Castro, Ana I.
    Sanchez-Iglesias, Sofia
    Cobelo-Gomez, Silvia
    Prado-Morana, Teresa
    Araujo-Vilar, David
    CELLS, 2023, 12 (05)
  • [8] Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants
    Sekizkardes, Hilal
    Cochran, Elaine
    Malandrino, Noemi
    Garg, Abhimanyu
    Brown, Rebecca J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (08): : 3068 - 3076
  • [9] A LMNA splicing mutation in two sisters with severe dunnigan-type familial partial lipodystrophy type 2
    Morel, Chantal F.
    Thomas, Mary Ann
    Cao, Henian
    O'Neil, Caroline H.
    Pickering, J. Geoffrey
    Foulkes, William D.
    Hegele, Robert A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07): : 2689 - 2695
  • [10] Myopathy in patients with familial partial lipodystrophy due to LMNA mutations
    Spuler, S
    Kalbhenn, T
    Schmidt, HJ
    NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 591 - 591
12345